{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:08:25Z","timestamp":1772892505756,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s15010-019-01362-x","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T08:04:21Z","timestamp":1570781061000},"page":"1037-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins"],"prefix":"10.1007","volume":"47","author":[{"given":"Atsushi","family":"Uda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-3507","authenticated-orcid":false,"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goh","family":"Ohji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Kusuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Izuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Sakaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Tokimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Miyara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"1362_CR1","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. https:\/\/www.who.int\/antimicrobial-resistance\/global-action-plan\/en\/ . 2015. Accessed 8 June 2019."},{"key":"1362_CR2","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013 United States, 2013. https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf . 2013. Accessed 8 June 2019."},{"key":"1362_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.15585\/mmwr.mm6509e1","volume":"65","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Fridkin SK, Aponte-Torres Z, et al. Vital signs: preventing antibiotic-resistant infections in hospitals\u2014United States, 2014. Morb Mortal Wkly Rep. 2016;65:235\u201341.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1362_CR4","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","volume":"315","author":"KE Fleming-Dutra","year":"2016","unstructured":"Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011. JAMA. 2016;315:1864\u201373.","journal-title":"JAMA"},{"key":"1362_CR5","doi-asserted-by":"publisher","first-page":"k5092","DOI":"10.1136\/bmj.k5092","volume":"364","author":"KP Chua","year":"2019","unstructured":"Chua KP, Fischer MA, Linder JA. Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study. BMJ. 2019;364:k5092. https:\/\/doi.org\/10.1136\/bmj.k5092 .","journal-title":"BMJ"},{"key":"1362_CR6","doi-asserted-by":"publisher","first-page":"k3155","DOI":"10.1136\/bmj.k3155","volume":"362","author":"SW Olesen","year":"2018","unstructured":"Olesen SW, Barnett ML, MacFadden DR, Lipsitch M, Grad YH. Trends in outpatient antibiotic use and prescribing practice among US older adults, 2011\u201315: observational study. BMJ. 2018;362:k3155. https:\/\/doi.org\/10.1136\/bmj.k3155 .","journal-title":"BMJ"},{"key":"1362_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","volume":"65","author":"GV Sanchez","year":"2016","unstructured":"Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep. 2016;65:1\u201312.","journal-title":"MMWR Recomm Rep."},{"key":"1362_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","volume":"315","author":"D Meeker","year":"2016","unstructured":"Meeker D, Linder JA, Fox CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA. 2016;315:562\u201370.","journal-title":"JAMA"},{"key":"1362_CR9","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0140-6736(16)00215-4","volume":"387","author":"M Hallsworth","year":"2016","unstructured":"Hallsworth M, Chadborn T, Sallis A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet. 2016;387:1743\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(16)00215-4 .","journal-title":"Lancet"},{"key":"1362_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/cid\/cir272","volume":"53","author":"G Regev-Yochay","year":"2011","unstructured":"Regev-Yochay G, Raz M, Dagan R, et al. Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis. 2011;53:33\u201341. https:\/\/doi.org\/10.1093\/cid\/cir272 .","journal-title":"Clin Infect Dis"},{"key":"1362_CR11","doi-asserted-by":"publisher","first-page":"d8173","DOI":"10.1136\/bmj.d8173","volume":"344","author":"CC Butler","year":"2012","unstructured":"Butler CC, Simpson SA, Dunstan F, et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ. 2012;344:d8173. https:\/\/doi.org\/10.1136\/bmj.d8173 .","journal-title":"BMJ"},{"key":"1362_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/ice.2014.41","volume":"36","author":"DM Drekonja","year":"2015","unstructured":"Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol. 2015;36:142\u201352. https:\/\/doi.org\/10.1017\/ice.2014.41 .","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1362_CR13","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"EY Klein","year":"2018","unstructured":"Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115:E3463\u201370.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1362_CR14","unstructured":"Centers for Disease Control and Prevention. Outpatient Antibiotic Prescriptions, United States, 2016. https:\/\/www.cdc.gov\/antibiotic-use\/community\/programs-measurement\/state-local-activities\/outpatient-antibiotic-prescriptions-US-2016.html . 2018. Accessed 8 June 2019."},{"key":"1362_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jgar.2016.07.002","volume":"7","author":"Y Muraki","year":"2016","unstructured":"Muraki Y, Yagi T, Tsuji Y, et al. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009\u20132013). J Glob Antimicrob Resist. 2016;7:19\u201323.","journal-title":"J Glob Antimicrob Resist."},{"key":"1362_CR16","unstructured":"The European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2012. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-consumption-europe-esac-net-2012.pdf . 2014. Accessed 8 June 2019."},{"key":"1362_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/512810","volume":"44","author":"H Goossens","year":"2007","unstructured":"Goossens H, Ferech M, Coenen S, Stephens P, European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091\u20135.","journal-title":"Clin Infect Dis"},{"key":"1362_CR18","doi-asserted-by":"crossref","DOI":"10.1201\/b13787","volume-title":"Kucers\u2019 the use of antibiotics","author":"M Lindsay Grayson","year":"2010","unstructured":"Lindsay Grayson M, Crowe SM, McCarthy JS, et al. Kucers\u2019 the use of antibiotics. 6th ed. USA: ASM Press; 2010.","edition":"6"},{"key":"1362_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/107662903764736337","volume":"9","author":"K Hasegawa","year":"2003","unstructured":"Hasegawa K, Yamamoto K, Chiba N, et al. Diversity of ampicillin resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39\u201346.","journal-title":"Microb Drug Resist."},{"key":"1362_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jiac.2014.11.012","volume":"21","author":"H Shiro","year":"2015","unstructured":"Shiro H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients\u2019 background factors. J Infect Chemother. 2015;21:247\u201356. https:\/\/doi.org\/10.1016\/j.jiac.2014.11.012 .","journal-title":"J Infect Chemother."},{"key":"1362_CR21","doi-asserted-by":"publisher","first-page":"e00851-18","DOI":"10.1128\/aac.00851-18","volume":"62","author":"H Honda","year":"2018","unstructured":"Honda H, Sato T, Shinagawa M, et al. Multiclonal expansion and high prevalence of \u03b2-lactamase-negative haemophilus influenzae with high-level ampicillin resistance in japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62:e00851-18. https:\/\/doi.org\/10.1128\/aac.00851-18 pii.","journal-title":"Antimicrob Agents Chemother."},{"key":"1362_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1128\/JCM.40.3.1063-1066.2002","volume":"40","author":"JA Karlowsky","year":"2002","unstructured":"Karlowsky JA, Critchley IA, Blosser-Middleton RS, et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000\u20132001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol. 2002;40:1063\u20136.","journal-title":"J Clin Microbiol"},{"key":"1362_CR23","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1007\/s10096-012-1623-9","volume":"31","author":"H Dabernat","year":"2012","unstructured":"Dabernat H, Delmas C. Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5\u00a0years of age or less in France, 2001-2008: a retrospective database analysis. Eur J Clin Microbiol Infect Dis. 2012;31:2745\u201353.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1362_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ped.12781","volume":"58","author":"T Okada","year":"2016","unstructured":"Okada T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan. Pediatr Int. 2016;58:192\u2013201. https:\/\/doi.org\/10.1111\/ped.12781 .","journal-title":"Pediatr Int"},{"key":"1362_CR25","unstructured":"The Government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016\u20132020. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf . 2016. Accessed 8 June 2019."},{"key":"1362_CR26","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance 2014. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/112642\/9789241564748_eng.pdf;jsessionid=15655CCA02D5864D4E8BB41CA697CE76?sequence=1 . 2014. Accessed 8 June 2019."},{"key":"1362_CR27","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1099\/jmm.0.059279-0","volume":"62","author":"Y Chong","year":"2013","unstructured":"Chong Y, Shimoda S, Yakushiji H, et al. Community spread of extended-spectrum \u03b2-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol. 2013;62:1038\u201343.","journal-title":"J Med Microbiol"},{"key":"1362_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jiac.2016.08.010","volume":"23","author":"K Hayakawa","year":"2017","unstructured":"Hayakawa K, Nagamatsu M, Mezaki K, et al. Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: Characteristics of community-associated versus healthcare-associated ESBL E. coli. J Infect Chemother. 2017;23:117\u20139.","journal-title":"J Infect Chemother."},{"key":"1362_CR29","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1542\/peds.2007-0339","volume":"120","author":"Y Makino","year":"2007","unstructured":"Makino Y, Sugiura T, Ito T, Sugiyama N, Koyama N. Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid. Pediatrics. 2007;120:e739\u201341.","journal-title":"Pediatrics"},{"key":"1362_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/ped.12305","volume":"56","author":"T Nasu","year":"2014","unstructured":"Nasu T, Suzuki M, Uetake K, Kubota M. Newborn hypocarnitinemia due to long-term transplacental pivalic acid passage. Pediatr Int. 2014;56:772\u20134. https:\/\/doi.org\/10.1111\/ped.12305 .","journal-title":"Pediatr Int"},{"key":"1362_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12887-017-0835-7","volume":"17","author":"M Ito","year":"2017","unstructured":"Ito M, Fukuda M, Suzuki Y, Wakamoto H, Ishii E. Carnitine-related hypoglycemia caused by 3\u00a0days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report. BMC Pediatr. 2017;17:73. https:\/\/doi.org\/10.1186\/s12887-017-0835-7 .","journal-title":"BMC Pediatr."},{"key":"1362_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1503\/cmaj.071812","volume":"179","author":"S Dial","year":"2008","unstructured":"Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767\u201372. https:\/\/doi.org\/10.1503\/cmaj.071812 .","journal-title":"CMAJ"},{"key":"1362_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s15010-017-1099-8","volume":"46","author":"T Kimura","year":"2018","unstructured":"Kimura T, Uda A, Sakaue T, et al. Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback. Infection. 2018;46:215\u201324. https:\/\/doi.org\/10.1007\/s15010-017-1099-8 .","journal-title":"Infection"},{"key":"1362_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195\u2013283. https:\/\/doi.org\/10.2146\/ajhp120568 .","journal-title":"Am J Health Syst Pharm"},{"key":"1362_CR35","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"W Wilson","year":"2007","unstructured":"Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736\u201354.","journal-title":"Circulation"},{"key":"1362_CR36","volume-title":"Performance standards for antimicrobial susceptibility testing, M100-S22","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, M100-S22. Wayne: CLSI; 2012."},{"key":"1362_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jiac.2018.10.002","volume":"25","author":"N Kinoshita","year":"2019","unstructured":"Kinoshita N, Morisaki N, Uda K, Kasai M, Horikoshi Y, Miyairi I. Nationwide study of outpatient oral antimicrobial utilization patterns for children in Japan (2013\u20132016). J Infect Chemother. 2019;25:22\u20137. https:\/\/doi.org\/10.1016\/j.jiac.2018.10.002 .","journal-title":"J Infect Chemother."},{"key":"1362_CR38","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an Antibiotic Stewardship Program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51\u201377.","journal-title":"Clin Infect Dis"},{"key":"1362_CR39","unstructured":"Ministry of Health, Labour and Welfare. Japan Nosocomial Infections Surveillance (JANIS): annual open report. 2016. https:\/\/janis.mhlw.go.jp\/english\/report\/open_report\/2016\/3\/1\/ken_Open_Report_Eng_201600_clsi2012.pdf . 2017. Accessed 8 June 2019."},{"key":"1362_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:990\u20131001. https:\/\/doi.org\/10.1016\/S1473-3099(17)30325-0 .","journal-title":"Lancet Infect Dis."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-019-01362-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T14:28:39Z","timestamp":1611498519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-019-01362-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1007\/s15010-019-01362-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T. Miyara has received grant support from Shionogi & Co., Ltd. The other authors reported no conflicts of interest relevant to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}